Osteoarthritis screening: Difference between revisions
No edit summary |
|||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
__NOTOC__ | __NOTOC__ | ||
{{Osteoarthritis}} | {{Osteoarthritis}} | ||
{{CMG}} {{AE}} | {{CMG}} ; {{AE}}[[User:DrMars|Mohammadmain Rezazadehsaatlou]][2], [[User:Irfan Dotani|Irfan Dotani]] [3] | ||
==Overview== | ==Overview== | ||
Routine screening for osteoarthritis is not indicated unless the patient is symptomatic. | |||
==Screening== | ==Screening== | ||
Accurate data about the prevalence of OA can be useful for the health care system to have appropriate plans for management of OA patients. Nowadays, the OA screening in general population depends on the self-reported symptoms recorded during the clinical evaluation. An approved screening algorithm OA with sufficient sensitivities and specificities is necessary for OA management. Due to the lack of a reliable screening test for OA, the assessments of the prevalence of OA in a general population is difficult. Meanwhile, some scientist have worked on the screening questionnaires for identifying the knee or hip OA. Using only a questionnaire to identify OA cases without the physical examinations and radiographs would be non-verifiable<ref name="pmid10750883">{{cite journal |vauthors=Manek NJ, Lane NE |title=Osteoarthritis: current concepts in diagnosis and management |journal=Am Fam Physician |volume=61 |issue=6 |pages=1795–804 |date=March 2000 |pmid=10750883 |doi= |url=}}</ref><ref name="pmid18077540">{{cite journal |vauthors=Roux CH, Saraux A, Mazieres B, Pouchot J, Morvan J, Fautrel B, Testa J, Fardellone P, Rat AC, Coste J, Guillemin F, Euller-Ziegler L |title=Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimates |journal=Ann. Rheum. Dis. |volume=67 |issue=10 |pages=1406–11 |date=October 2008 |pmid=18077540 |doi=10.1136/ard.2007.075952 |url=}}</ref><ref name="pmid18077540">{{cite journal |vauthors=Roux CH, Saraux A, Mazieres B, Pouchot J, Morvan J, Fautrel B, Testa J, Fardellone P, Rat AC, Coste J, Guillemin F, Euller-Ziegler L |title=Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimates |journal=Ann. Rheum. Dis. |volume=67 |issue=10 |pages=1406–11 |date=October 2008 |pmid=18077540 |doi=10.1136/ard.2007.075952 |url=}}</ref>. | |||
==References== | ==References== | ||
Latest revision as of 20:35, 16 June 2018
|
Osteoarthritis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Osteoarthritis screening On the Web |
|
American Roentgen Ray Society Images of Osteoarthritis screening |
|
Risk calculators and risk factors for Osteoarthritis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Mohammadmain Rezazadehsaatlou[2], Irfan Dotani [3]
Overview
Routine screening for osteoarthritis is not indicated unless the patient is symptomatic.
Screening
Accurate data about the prevalence of OA can be useful for the health care system to have appropriate plans for management of OA patients. Nowadays, the OA screening in general population depends on the self-reported symptoms recorded during the clinical evaluation. An approved screening algorithm OA with sufficient sensitivities and specificities is necessary for OA management. Due to the lack of a reliable screening test for OA, the assessments of the prevalence of OA in a general population is difficult. Meanwhile, some scientist have worked on the screening questionnaires for identifying the knee or hip OA. Using only a questionnaire to identify OA cases without the physical examinations and radiographs would be non-verifiable[1][2][2].
References
- ↑ Manek NJ, Lane NE (March 2000). "Osteoarthritis: current concepts in diagnosis and management". Am Fam Physician. 61 (6): 1795–804. PMID 10750883.
- ↑ 2.0 2.1 Roux CH, Saraux A, Mazieres B, Pouchot J, Morvan J, Fautrel B, Testa J, Fardellone P, Rat AC, Coste J, Guillemin F, Euller-Ziegler L (October 2008). "Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimates". Ann. Rheum. Dis. 67 (10): 1406–11. doi:10.1136/ard.2007.075952. PMID 18077540.